Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy

Leukemia Research

Volumn 34, Issue 1, 2010, Pages

  Lee, Ji Hyun ^a   Kwon, Kyung A ^a   Lee, Suee ^a   Oh, Sung Yong ^a   Kwon, Hyuk Chan ^a   Han, Jin Yeong ^a   Hong, Sook Hee ^a   Kim, Sung Hyun ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; EPITHELIAL MEMBRANE ANTIGEN; FUROSEMIDE; PREDNISOLONE; PROTEIN UCHL 1; REGULATOR PROTEIN; SYNDECAN 1; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTERIAL GAS; BLOOD EXAMINATION; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSPNEA; FEVER; FLUID THERAPY; HUMAN; HYPOTENSION; KIDNEY FAILURE; LETTER; MALE; METABOLIC ACIDOSIS; MULTICENTRIC CASTLEMAN DISEASE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RELAPSE; SYSTEMIC THERAPY; TUMOR LYSIS SYNDROME;

ADULT; ANTINEOPLASTIC AGENTS; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; TUMOR LYSIS SYNDROME;

EID: 73249137716     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.08.025     Document Type: Letter

References (16)

1. Castleman B., and Towne V. Case records of the Massachusetts General Hospital: Case No. 40231. N Engl J Med 250 (1954) 1001-1005
2. Soulier J., Grollet L., Oksenhendler E., et al. Kaposi' sarcoma-associated herpes virus-like DNA sequences in multicentric Castleman's disease. Blood 86 4 (1995) 1276-1280
3. Yoshizaki K., Matsuda T., Nishimoto H., et al. Pathogenic significance of interleukin-6 (IL-5/BSF-2) in Castleman's disease. Blood 74 (1989) 1360-1367
4. Keller A.R., Hochholzer L., and Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29 (1972) 670-683
5. McCarthy M., Vukelja S., Banks P., et al. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev 21 (1995) 291-310
6. Dupin N., Diss T.L., Kellam P., et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-positive plasmablastic lymphoma. Blood 95 (2000) 1406-1412
7. Frizzera G., Peterson B.A., Bayrd E.D., et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3 (1985) 1202-1216
8. Chronowski G.M., Ha C.S., Wilder R.B., et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92 (2001) 670-676
9. Lee K.D., Lee K.W., Choi I.S., et al. Multicentric Castleman's disease complicated by tumor lysis syndrome. Ann Hematol 83 (2004) 722-725
10. Cairo M.S., and Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127 (2004) 3-11
11. Del Toro G., Morris E., and Cairo M.S. Tumor lysis syndrome: pathophysiology, definition, and alternative treatment approaches. Clin Adv Hematol Oncol 3 (2005) 54-61
12. Oksenhendler E., Boulanger E., Galicier L., et al. High incidence of Kaposi sarcoma-associated herpes virus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99 (2002) 2331-2336
13. Peterson B.A., and Frizzera G. Multicentric Castleman's disease. Semin Oncol 20 (1993) 636-647
14. Larroche C., Cacoub P., Soulier J., et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 69 (2002) 119-126
15. Belhadj K., Reyes F., Farcet J.P., et al. Hepatosplenic γ-δ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102 (2003) 4261-4269
16. Gaulard P., Jaffe E., Krenacs L., et al. Hepatosplenic T-cell lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC, Lyon 292-293